Phase II Trial of Vistusertib（AZD2014） Single Agent in TSC1or 2 Null or TSC 1/2 Mutation Solid Cancer Patients Refractory to Standard Chemotherapy
Clinical trial NCT03166176 · WITHDRAWN
Trial details
- NCT number
- NCT03166176
- Sponsor
- Samsung Medical Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2018-07-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.